Back to search

France· FR:62469022

LEVOTONINE 100 mg, gélule

A oxitriptan product containing oxitriptan, registered in France by PANPHARMA, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC N06AX01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedLEVOTONINE 100 mg, géluleATCN06AX01REGISTER NO.FR:62469022PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Oxitriptan is registered in 4 of 19 countries.

Countries holding a registration under ATC N06AX01 (oxitriptan), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 3 of them publish a price we can compare per daily dose

Oxitriptan · ATC N06AX01

4 / 19 countries

  • Franceprice
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
OXITRIPTAN
Manufacturer
PANPHARMA
Country
France (FR)
ATC code
N06AX01
ATC class
Oxitriptan
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400933338022
    1 flacon(s) en verre de 100 gélule(s)
    EUR 40.24

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

21 interactions on record for oxitriptan.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Oxitriptan · interactions on record

21 records

  • 12 severe
  • 9 moderate

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxitriptan in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxitriptan products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Italy · Tript-Oh
  • Lithuania · Triptosan
  • Portugal · Cincofarm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ebc73939-aa31-45b2-b2b0-76c29bb451fc
GET /v1/drugs/ebc73939-aa31-45b2-b2b0-76c29bb451fc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62469022",
  "date_amm": "1981-02-20",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "OXITRIPTAN",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about oxitriptan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.